Home » Elron Announces New Investment of $2.9 Million in Nulens
Elron Announces New Investment of $2.9 Million in Nulens
Elron Electronic Industries announced a new investment of approximately $2.9 million in Nulens, an Israeli medical devices company operating in the field of intraocular lenses mainly for cataract and presbyopia procedures. Nulens is developing a novel fully accommodative intraocular lens (IOL) and is currently conducting preclinical trials. The investment will be in two installments.
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct